Rothschild & Co Initiates Coverage on Stryker Corp (SYK) at Neutral
Rothschild & Co begins coverage of Stryker Corp (SYK) with a Neutral rating.
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. The company is headquartered in Portage, Michigan and currently employs 53,000 full-time employees. The firm offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The firm also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
Latest news, analyst ratings, earnings reports, dividends, insider trades, and market analysis for Stryker Corp.
Last Updated: Dec 11, 2025, 11:03 PM · Source: Finnhub.io
Rothschild & Co begins coverage of Stryker Corp (SYK) with a Neutral rating.
Stryker Corp (SYK) insider Ronda E. Stryker sells 3 million shares valued at $1.1 billion.
Stryker Corp (SYK) reported Q3 2025 EPS of $3.19 and revenue of $6.1B, meeting analyst expectations.